Northwestern Mutual Wealth Management’s Corcept Therapeutics CORT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87	Buy	+1	New	+$60	﹤0.01%	3997
2026 Q1	–	Sell	-156	Closed	-$5.43K	–	4192
2025 Q4	$5.43K	Buy	156 +145	+1,318%	+$11.4K	﹤0.01%	3201
2025 Q3	$914	Buy	+11	New	+$796	﹤0.01%	3568
2024 Q4	–	Sell	-72	Closed	-$3.33K	–	3659
2024 Q3	$3.33K	Buy	+72	New	+$2.56K	﹤0.01%	3010
2024 Q1	–	Sell	-20	Closed	-$650	–	3608
2023 Q4	$650	Buy	+20	New	+$549	﹤0.01%	3240
2022 Q3	–	Sell	-50	Closed	-$1K	–	3161
2022 Q2	$1K	Buy	+50	New	+$1.09K	﹤0.01%	3013
2018 Q4	–	Sell	-115	Closed	-$2K	–	2421
2018 Q3	$2K	Sell	115 -2,172	-95%	-$30.4K	﹤0.01%	2262
2018 Q2	$36K	Buy	+2,287	New	+$39.8K	﹤0.01%	1369

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northwestern Mutual Wealth Management's CORT Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 1 share worth $87. The stake represents ﹤0.01% of the portfolio and ranks #3997 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in CORT as recently as Q4 2025.

Northwestern Mutual Wealth Management first reported a position in CORT in Q2 2018 and has held it in 8 quarters since. The position peaked at $36K in Q2 2018. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Northwestern Mutual Wealth Management held 1 share of Corcept Therapeutics worth $87 as of Q2 2026.
Corcept Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3997 holding.
Northwestern Mutual Wealth Management first reported a position in Corcept Therapeutics in Q2 2018 and has held it in 8 quarters since.
Northwestern Mutual Wealth Management's Corcept Therapeutics position peaked at $36K in Q2 2018.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.